Research Article
Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes
Table 3
Logistic regression models for variables associated with the presence of coronary artery stenosis.
| | | OR (95% CI) | value | OR (95% CI) | value | OR (95% CI) | value | OR (95% CI) | value |
| | Age | 1.13 (1.00–1.28) | 0.042 | 1.16 (1.01–1.32) | 0.033 | 1.14 (1.01–1.29) | 0.033 | 1.18 (1.02–1.37) | 0.031 | | Male sex | 3.00 (0.33–27.7) | 0.332 | 3.13 (0.27–36.1) | 0.360 | 3.53 (0.29–42.3) | 0.320 | 4.99 (0.24–104.4) | 0.300 | | BMI | 1.16 (0.94–1.44) | 0.172 | 1.13 (0.90–1.43) | 0.288 | 1.15 (0.92–1.44) | 0.218 | 1.10 (0.84–1.43) | 0.485 | | Hypertension | 0.28 (0.02–4.11) | 0.353 | 0.17 (0.01–3.28) | 0.239 | 0.24 (0.01–4.95) | 0.357 | 0.16 (0.01–5.06) | 0.301 | | Duration of diabetes | 1.17 (1.01–1.35) | 0.031 | 1.16 (0.99–1.36) | 0.068 | 1.20 (1.02–1.42) | 0.031 | 1.23 (0.99–1.54) | 0.063 | | Smoking | 0.27 (0.03–2.14) | 0.216 | 0.16 (0.02–1.77) | 0.136 | 0.25 (0.03–2.19) | 0.211 | 0.12 (0.01–1.94) | 0.135 | | HbA1c | 1.20 (0.58–2.50) | 0.627 | 1.37 (0.61–3.10) | 0.450 | 1.27 (0.59–2.74) | 0.547 | 1.50 (0.62–3.62) | 0.365 | | MDA-LDL | 1.02 (1.00–1.04) | 0.039 | — | — | — | — | — | — | | MDA-LDL/LDL-C (per U/mmol increment) | — | — | 1.13 (1.03–1.25) | 0.013 | — | — | — | — | | MDA-LDL/HDL-C (per U/mmol increment) | — | — | — | — | 1.02 (1.00–1.05) | 0.047 | — | — | | (MDA-LDL/LDL-C)/HDL-C (per U·L/mmol2 increment) | — | — | — | — | — | — | 1.16 (1.03–1.30) | 0.013 |
|
|
BMI: body mass index; hypertension: systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg or treatment; MDA-LDL: malondialdehyde-modified LDL; MDA-LDL-C/LDL-C: MDA-LDL-to-LDL cholesterol ratio; MDA-LDL-C/HDL-C: MDA-LDL-to-HDL cholesterol ratio; (MDA-LDL/LDL-C)/HDL-C: (MDA-LDL/LDL-C) to HDL cholesterol ratio.
|
